Patient-Derived Xenograft/PDX Model Market overview by recent opportunities, growth size, regional analysis and forecasts to 2031 | Xentech, Xenopat, EUROPDX

New York, 2022-Jul-14 — /EPR Network/ — Global Patient-Derived Xenograft/PDX Model Market report from Global Insight Services is the single authoritative source of intelligence on Patient-Derived Xenograft/PDX Model Market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters’ and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types, applications, and geographies. Report also includes comprehensive analysis of key issues, trends and drivers, restraints and challenges, competitive landscape, as well as recent events such as M&A activities in the market.

A patient-derived xenograft (PDX) is a cancer model created by transplanting tumor tissue from a human patient into an immunodeficient animal. This allows researchers to study the tumor in a living system and to test potential treatments.

Download Free Sample of Report –

Key Trends

There are a few key trends in Patient-Derived Xenograft/PDX Model technology. First, there is a trend towards using PDX models to study more rare diseases. This is because PDX models can provide a more accurate representation of the disease than cell lines or other models. Additionally, PDX models can be used to study the disease in its natural environment, which can provide insights that would not be possible with other model types. Another trend is the use of PDX models to study the efficacy of new treatments. This is because PDX models can be used to test the effectiveness of a treatment in a more realistic setting. Additionally, PDX models can be used to study the side effects of a treatment, which is important for safety purposes.

Key Drivers

The key drivers of the Patient-Derived Xenograft/PDX Model market are the increasing incidence of cancer, the availability of PDX models for a wide range of cancer types, and the increasing use of PDX models in drug development. The incidence of cancer is increasing globally, with an estimated 18.1 million new cases and 9.6 million cancer-related deaths in 2018. The availability of PDX models for a wide range of cancer types is a key driver of the PDX market.

Key Market Segments

By Type

  • Mice Models
  • Rat Models

By Tumor Type

  • Lung Tumor Models
  • Respiratory Tumor Models

By Application

  • Precision Medicine
  • Co-Clinical Trials

By End User

  • Academic and Research Organizations
  • Contract Research Organizations
  • Pharmaceutical and Biotechnological Companies

By Region

  • North America
    • The U.S.

Request For Customization –

Key Market Players

  • Xentech
  • Xenopat
  • Hera Biolabs
  • Bioduro
  • Envigo
  • Urosphere
  • Wuxi Apptech
  • Oncodesign

With Global Insight Services, you receive:

  • 10-year forecast to help you make strategic decisions
  • In-depth segmentation which can be customized as per your requirements
  • Free consultation with lead analyst of the report
  • Excel data pack included with all report purchases
  • Robust and transparent research methodology

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
Phone: +1–833–761–1700

Matched content

Editor’s pick

Express Press Release Distribution